Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Advises DiDi Chuxing with its investment in NEVS
Mandate

Advises DiDi Chuxing with its investment in NEVS

October 30, 2017 Automotive, Mobility and Electrification

Vinge has advised DiDi Chuxing in connection with its investment in the form of convertible loans in the Swedish electric car manufacturer National Electric Vehicle Sweden AB (NEVS).

The investment is part of a larger partnership agreement between DiDi Chuxing and NEVS, which includes both investment in NEVS and purchase of NEVS’ cars. DiDi Chuxing is the world’s largest provider of app-based taxi and ride-sharing services with around 400 million rides annually.

Vinge’s team consisted of partner Albert Wållgren and associates Helena Håkansson, Malte Hedlund and Elias Lundin.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026